A phase I study of<scp>ABT</scp>‐510 plus bevacizumab in advanced solid tumors

Hope E. Uronis(Duke Medical Center), Herbert I. Hurwitz(Duke Medical Center)

Cancer Medicine

March 21, 2013

10.1002/cam4.65

Cited by 28

Related Papers

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

|Journal of Clinical Oncology|2010|840

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

|The Lancet Oncology|2019|564

Metastatic Pancreatic Cancer: ASCO Guideline Update

|Journal of Clinical Oncology|2020|287

Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials

|The Oncologist|2013|235

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

|The Lancet Oncology|2020|190